DORONZO, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 1.374
EU - Europa 804
AS - Asia 536
AF - Africa 11
OC - Oceania 4
SA - Sud America 1
Totale 2.730
Nazione #
US - Stati Uniti d'America 1.363
CN - Cina 303
IT - Italia 170
IE - Irlanda 136
SG - Singapore 129
SE - Svezia 97
FI - Finlandia 85
UA - Ucraina 80
FR - Francia 74
DE - Germania 65
KR - Corea 50
GB - Regno Unito 35
PL - Polonia 26
VN - Vietnam 20
AT - Austria 13
BE - Belgio 11
CA - Canada 10
HK - Hong Kong 10
JP - Giappone 8
SN - Senegal 8
IN - India 7
FJ - Figi 3
RU - Federazione Russa 3
CH - Svizzera 2
IR - Iran 2
LK - Sri Lanka 2
NG - Nigeria 2
NL - Olanda 2
TW - Taiwan 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
DK - Danimarca 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
MU - Mauritius 1
MX - Messico 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 2.730
Città #
Beijing 181
Chandler 140
Dublin 136
Singapore 104
Houston 84
Wilmington 82
Jacksonville 78
Torino 66
Ann Arbor 64
Fairfield 64
Villeurbanne 62
Nyköping 58
Medford 48
Princeton 45
Dearborn 40
Ashburn 38
Woodbridge 36
Fremont 35
Santa Clara 32
Turin 31
New York 27
Warsaw 23
Cambridge 22
Milan 17
Boston 14
Guangzhou 13
Seattle 13
Vienna 13
Pisa 12
Brussels 11
Dong Ket 11
Nanjing 11
Hangzhou 10
Detroit 9
Falls Church 9
Hefei 8
Kunming 8
Norwalk 8
Boardman 7
Redwood City 7
Hong Kong 5
San Jose 5
Toronto 5
Verona 5
Xian 5
Fuzhou 4
Helsinki 4
San Diego 4
Genova 3
Lachine 3
London 3
Nanchang 3
Redmond 3
San Mateo 3
Shanghai 3
Shenyang 3
Silver Spring 3
Abuja 2
Colombo 2
Hebei 2
Hyderabad 2
Kharkiv 2
Lausanne 2
Leawood 2
Pittsburgh 2
Rome 2
Seoul 2
Shaoxing 2
Taipei 2
Upper Marlboro 2
Wuhan 2
Zhengzhou 2
Alessandria 1
Amsterdam 1
Auburn Hills 1
Bethesda 1
Bunkyo-ku 1
Cavallermaggiore 1
Central 1
Centrale 1
Changsha 1
Cherasco 1
Chongqing 1
Columbia 1
Coushatta 1
Deland 1
Dogliani 1
Düsseldorf 1
Genoa 1
Gloucester 1
Guiyang 1
Haikou 1
Herndon 1
Huzhou 1
Jinan 1
Kilburn 1
Kowloon 1
Langfang 1
Las Vegas 1
Ljubljana 1
Totale 1.799
Nome #
CCL16 activates an angiogenic program in vascular endothelial cells 247
TFEB controls vascular development by regulating the proliferation of endothelial cells 145
High glucose reduces the anti-aggregating effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 119
A short-term incubation with high glucose impairs VASP phosphorylation at serine 239 in response to the nitric oxide/cGMP pathway in vascular smooth muscle cells: role of oxidative stress. 114
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 93
Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein 88
Multifaceted activities of transcription factor eb in cancer onset and progression 83
Contribution of insulin resistance to vascular dysfunction 81
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance 79
High glucose reduces the anti-aggreganting effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 78
Aspirin resistant subjects present a proinflammatory milieu with an increased oxidative stress: in these conditions, high glucose fails to influence platelet responses to agonists. 76
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin 76
Relevance of the vascular effects of insulin in the rationale of its therapeutical use 75
Effects of high glucose on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells from obese and lean zucker rats. 74
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets. 71
Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling 69
C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells 62
Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress. 62
Il miglioramento del controllo glicemico riduce la resistenza piastrinica all'aspirina nei pazienti affetti da diabete di tipo 2 61
Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase. 60
L'acido oleico incrementa trascrizione, sintesi e secrezione del VEGF in cellule muscolari lisce vascolari aortiche: ridotto effetto in condizioni di insulino-resistenza 59
Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway. 58
Role of NMDA receptor in homocysteine-induced activation of Mitogen-Activated Protein Kinase and Phosphatidyl Inositol 3-Kinase pathways in cultured human vascular smooth muscle cells 57
The Oncogene Transcription Factor EB Regulates Vascular Functions 57
Leptin and vascular smooth muscle cells. 56
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. 51
Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity. 50
A short-term improvement of blood glucose control increases aspirin sensitivity in aspirin-resistant type 2 diabetic men. 50
Influence of oleic acid on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells: signalling molecules involved and role of insulin resistance 50
High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism 49
An intensive control of blood glucose improves platelet sensitivity to aspirin in type 2 diabetes mellitus. 47
Acido oleico e regolazione del VEGF in cellule muscolari lisce vascolari aortiche in condizioni di insulino-sensibilità e insulino-resistenza. 47
Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress 42
Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways 39
Influenza dell’alto glucosio sull’aggregazione piastrinica in soggetti aspirino-trattati. 38
Non-HDL cholesterol is a determinant of aspirin-resistance in type 2 diabetes mellitus. 37
Sodium azide in commercially available C-reactive protein preparations does not influence matrix metalloproteinase-2 synthesis and release in cultured human aortic vascular smooth muscle cells 37
TFEB controls integrin-mediated endothelial cell adhesion by the regulation of cholesterol metabolism 35
The TFEB-TGIF1 axis regulates EMT in mouse epicardial cells 34
Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity 30
Transcription factor EB controls both motogenic and mitogenic cell activities 23
Dual VEGFA/BRAF targeting boosts PD-1 blockade in melanoma through GM-CSF-mediated infiltration of M1 macrophages 21
Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer 19
TFEB inhibition induces melanoma shut-down by blocking the cell cycle and rewiring metabolism 15
TFEB Signalling-Related MicroRNAs and Autophagy 14
The tissue-specific transcriptional landscape underlines the involvement of endothelial cells in health and disease 11
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer 9
Totale 2.848
Categoria #
all - tutte 10.441
article - articoli 0
book - libri 0
conference - conferenze 2.188
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020379 0 0 18 45 27 92 50 17 47 34 19 30
2020/2021267 30 25 31 9 10 8 16 5 32 39 18 44
2021/2022369 15 13 17 12 14 19 18 13 11 32 122 83
2022/2023546 53 47 12 34 59 144 52 31 59 12 33 10
2023/2024290 33 59 12 25 14 49 11 5 3 8 22 49
2024/2025185 7 154 24 0 0 0 0 0 0 0 0 0
Totale 2.848